Welcome to the Articles section of Nutramedic&Cosmetics, a rich repository of articles that delve into the many facets of the food supplements and cosmetics industry.
Our “Articles” section features a wide range of topics, providing you with in-depth knowledge and insights. From the latest scientific research in food supplements to the newest trends in cosmetics, our articles cover it all. They are written by industry experts and thought leaders, ensuring you get accurate and reliable information.
Saanroo announced the publication of a human clinical trial evaluating Trpti™, its bioavailable form of oleoylethanolamide (OEA), in overweight adults. The study, published in Gut Microbes Reports, demonstrated targeted modulation of the gut microbiome, along with assessments of intestinal barrier function and inflammatory signaling.
This third part of the series focuses on practical, real-world issues that repeatedly appear in small-scale cosmetic production – not as isolated mistakes, but as structural challenges resulting from limited access to regulatory knowledge, technical training, and industry-standard manufacturing practices.
AUTHOR: Gordana Gorinšek, MSc in Phytomedicine
Senior Cosmetic Safety Assessor
Expert Regulatory Affairs Consultant
Acne vulgaris is increasingly recognized not merely as a localized skin disorder, but as a complex systemic condition influenced by hormonal, metabolic, and microbial factors. Emerging evidence highlights the pivotal role of insulin signaling and gut microbiome dysbiosis in driving inflammation and sebaceous activity. This evolving perspective supports a shift toward integrative therapeutic strategies targeting the gut–skin axis.
Authors: Emanuela Krpan, MSc, Master in Nutrition.
Paola Pavačić, MSc. Microbiome in Health and Disease
Next-generation joint and mobility actives in food supplements are reshaping musculoskeletal health by moving beyond traditional ingredients like glucosamine and chondroitin toward multi-targeted solutions including bioactive collagen peptides, advanced botanical extracts, and microbiome-modulating probiotics. Driven by the rapidly aging population projected, these nutraceuticals aim to support joint comfort, cartilage integrity, and long-term mobility through evidence-based, synergistic mechanisms.
Author: Daria Šurić, Mpharm, univ.spec.
Plant-based protein is emerging as a sustainable, high-quality alternative to animal protein, supporting muscle health, weight management, and overall nutrition while significantly reducing environmental impact and greenhouse gas emissions. As demand for sustainable diets grows, plant protein sources such as legumes, soy, and microalgae are reshaping the future of healthy, eco-friendly nutrition.
Author: Lucija Sobotinčić, Msc.Nutrition
This review examines cannabidiol (CBD) as a non-psychotropic cannabinoid with growing clinical and nutraceutical relevance. It highlights regulatory-approved CBD medicines and focuses on novel lipid-based formulations designed to improve oral bioavailability. Results from two randomized crossover studies demonstrate enhanced absorption, sex-dependent pharmacokinetics, and CYP450 genotype – related metabolic differences using a lipophilic CBD formulation. Improved cardiovascular outcomes and minimal adverse effects were observed. The findings emphasize the importance of personalized dosing, advanced delivery systems, and improved professional education on CBD use.
Author: Ana Batinić, M.pharm, PhD in Toxycology
Saanroo announced the publication of a human clinical trial evaluating Trpti™, its bioavailable form of oleoylethanolamide (OEA), in overweight adults. The study, published in Gut Microbes Reports, demonstrated targeted modulation of the gut microbiome, along with assessments of intestinal barrier function and inflammatory signaling.
This third part of the series focuses on practical, real-world issues that repeatedly appear in small-scale cosmetic production – not as isolated mistakes, but as structural challenges resulting from limited access to regulatory knowledge, technical training, and industry-standard manufacturing practices.
AUTHOR: Gordana Gorinšek, MSc in Phytomedicine
Senior Cosmetic Safety Assessor
Expert Regulatory Affairs Consultant
Acne vulgaris is increasingly recognized not merely as a localized skin disorder, but as a complex systemic condition influenced by hormonal, metabolic, and microbial factors. Emerging evidence highlights the pivotal role of insulin signaling and gut microbiome dysbiosis in driving inflammation and sebaceous activity. This evolving perspective supports a shift toward integrative therapeutic strategies targeting the gut–skin axis.
Authors: Emanuela Krpan, MSc, Master in Nutrition.
Paola Pavačić, MSc. Microbiome in Health and Disease
Next-generation joint and mobility actives in food supplements are reshaping musculoskeletal health by moving beyond traditional ingredients like glucosamine and chondroitin toward multi-targeted solutions including bioactive collagen peptides, advanced botanical extracts, and microbiome-modulating probiotics. Driven by the rapidly aging population projected, these nutraceuticals aim to support joint comfort, cartilage integrity, and long-term mobility through evidence-based, synergistic mechanisms.
Author: Daria Šurić, Mpharm, univ.spec.
Plant-based protein is emerging as a sustainable, high-quality alternative to animal protein, supporting muscle health, weight management, and overall nutrition while significantly reducing environmental impact and greenhouse gas emissions. As demand for sustainable diets grows, plant protein sources such as legumes, soy, and microalgae are reshaping the future of healthy, eco-friendly nutrition.
Author: Lucija Sobotinčić, Msc.Nutrition
This review examines cannabidiol (CBD) as a non-psychotropic cannabinoid with growing clinical and nutraceutical relevance. It highlights regulatory-approved CBD medicines and focuses on novel lipid-based formulations designed to improve oral bioavailability. Results from two randomized crossover studies demonstrate enhanced absorption, sex-dependent pharmacokinetics, and CYP450 genotype – related metabolic differences using a lipophilic CBD formulation. Improved cardiovascular outcomes and minimal adverse effects were observed. The findings emphasize the importance of personalized dosing, advanced delivery systems, and improved professional education on CBD use.
Author: Ana Batinić, M.pharm, PhD in Toxycology
Welcome to B2B Nutramedic&Cosmetics web platform, your premier web platform and digital magazine for professionals in the food supplements and cosmetics industry.
Our mission is to provide the latest industry news, research, and insights to help you stay ahead in your field.
Terms of use | Privacy policy
DARMELL d.o.o. za usluge
Cvjetna cesta 11
10 000 Zagreb, Hrvatska
Telefon: +385 (91) 681 24 44
MB: 05638950
OIB: 81797383386
IBAN HR7124020061101112680
ERSTE&STEIERMARKISHE BANK d.d.,
Temeljni kapital u iznosu 20.000,00 kn plaćen u cijelosti
Direktor: Daria Šurić
Contact | About us | Advertise
Terms of use | Privacy policy
DARMELL d.o.o. za usluge | Cvjetna cesta 11, 10 000 Zagreb, Hrvatska | Telefon: +385 (91) 681 24 44 | MB: 05638950 | OIB: 81797383386 | IBAN HR7124020061101112680 ERSTE&STEIERMARKISHE BANK d.d. | Temeljni kapital u iznosu 20.000,00 kn plaćen u cijelosti | Direktor: Daria Šurić
© 2023 B2B NUTRAMEDIC & COSMETICS
Designed&Developed by: BoomBushBoo